oral myoma vaccine V3-myoma
Term · Oncology and biomedicine · MLC-T-ONC-015699
An orally available therapeutic myoma vaccine containing pooled antigens derived from hydrolyzed, inactivated blood and tumor tissue samples from patients with uterine myoma, with potential antineoplastic and immunomodulatory activities. Upon oral administration, V3-myoma may stimulate the immune system to mount a cytotoxic T-lymphocyte-mediated response against cells expressing myoma-associated antigens. This may reduce the myoma growth and improve myoma-related symptoms.
| Identifier | MLC-T-ONC-015699 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | V3-myoma; V3 myoma; V3-myoma vaccine; V3 myoma vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015699",
"term": "oral myoma vaccine V3-myoma",
"field": "Oncology and biomedicine",
"definition": "An orally available therapeutic myoma vaccine containing pooled antigens derived from hydrolyzed, inactivated blood and tumor tissue samples from patients with uterine myoma, with potential antineoplastic and immunomodulatory activities. Upon oral administration, V3-myoma may stimulate the immune system to mount a cytotoxic T-lymphocyte-mediated response against cells expressing myoma-associated antigens. This may reduce the myoma growth and improve myoma-related symptoms.",
"synonyms": [
"V3-myoma",
"V3 myoma",
"V3-myoma vaccine",
"V3 myoma vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/oral-myoma-vaccine-v3-myoma/"
}
Record 12,324 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.